Dione T. Kobayashi
Affiliations: | Rinat Labs |
Area:
Neurodegeneration, NeurobiologyGoogle:
"Dione Kobayashi"Mean distance: 14.94 (cluster 36)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Arnold WD, Duque S, Iyer CC, et al. (2016) Normalization of Patient-Identified Plasma Biomarkers in SMNΔ7 Mice following Postnatal SMN Restoration. Plos One. 11: e0167077 |
| Burghes A, Arnold W, McGovern V, et al. (2015) Response of biomarkers to treatment in mouse models of spinal muscular atrophy and response of SMA mice to later treatment Neuromuscular Disorders. 25: S193 |
| Marjańska M, Weigand SD, Preboske G, et al. (2014) Treatment effects in a transgenic mouse model of Alzheimer's disease: a magnetic resonance spectroscopy study after passive immunization. Neuroscience. 259: 94-100 |
| Kobayashi DT, Shi J, Stephen L, et al. (2013) SMA-MAP: a plasma protein panel for spinal muscular atrophy. Plos One. 8: e60113 |
| Osborne M, Gomez D, Feng Z, et al. (2012) Characterization of behavioral and neuromuscular junction phenotypes in a novel allelic series of SMA mouse models. Human Molecular Genetics. 21: 4431-47 |
| Finkel RS, Crawford TO, Swoboda KJ, et al. (2012) Candidate proteins, metabolites and transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) clinical study. Plos One. 7: e35462 |
| Crawford TO, Paushkin SV, Kobayashi DT, et al. (2012) Evaluation of SMN protein, transcript, and copy number in the biomarkers for spinal muscular atrophy (BforSMA) clinical study. Plos One. 7: e33572 |
| La Porte SL, Bollini SS, Lanz TA, et al. (2012) Structural basis of C-terminal β-amyloid peptide binding by the antibody ponezumab for the treatment of Alzheimer's disease. Journal of Molecular Biology. 421: 525-36 |
| Kobayashi DT, Olson RJ, Sly L, et al. (2011) Utility of survival motor neuron ELISA for spinal muscular atrophy clinical and preclinical analyses. Plos One. 6: e24269 |
| Ding JD, Johnson LV, Herrmann R, et al. (2011) Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. Proceedings of the National Academy of Sciences of the United States of America. 108: E279-87 |